Nautilus Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$642K Buy
555
+47
+9% +$55.5K 0.39% 73
2026
Q2
$604K Buy
508
+9
+2% +$9.2K 0.36% 80
2026
Q1
$459K Buy
499
+4
+0.8% +$4.05K 0.31% 89
2025
Q4
$532K Hold
495
– – 0.35% 79
2025
Q3
$378K Hold
495
– – 0.25% 109
2025
Q2
$386K Buy
495
+1
+0.2% +$777 0.28% 96
2025
Q1
$408K Hold
494
– – 0.34% 82
2024
Q4
$382K Buy
+494
New +$409K 0.3% 90

Other funds holding LLY

Nautilus Advisors's LLY Position: Q3 2026 in Review

Nautilus Advisors increased its Eli Lilly (LLY) stake by 9.3% in Q3 2026, buying an estimated $55.5K and bringing the position to 555 shares worth $642K. The position accounts for 0.39% of the portfolio, ranked #73.

Nautilus Advisors first reported a position in LLY in Q4 2024 and has held it in 8 quarters since. 255 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Nautilus Advisors held 555 shares of Eli Lilly worth $642K as of Q3 2026.
  • Nautilus Advisors bought 47 Eli Lilly shares in Q3 2026, an estimated $55.5K.
  • Eli Lilly made up 0.39% of Nautilus Advisors's portfolio in Q3 2026, its #73 holding.
  • Nautilus Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 8 quarters since.
  • 255 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Nautilus Advisors's 13F filing for Q3 2026, filed 7 Oct 2026.